InvestorsHub Logo

lasers

04/28/14 5:31 PM

#12227 RE: $Moneypenny$ #12226

Yes you have it right!

erostratus

04/28/14 5:55 PM

#12231 RE: $Moneypenny$ #12226

Yes. Plus Merck has made it a point that they're looking at early stage immunotherapy companies (plural) to supplement their pipeline programs. If we're to take them at their word, AGEN is just one of many.